Literature DB >> 20980613

Differential contributions of the primate ventrolateral prefrontal and orbitofrontal cortex to serial reversal learning.

Rafal Rygula1, Susannah C Walker, Hannah F Clarke, Trevor W Robbins, Angela C Roberts.   

Abstract

The discrimination reversal paradigm is commonly used to measure a subject's ability to adapt their behavior according to changes in stimulus-reward contingencies. Human functional neuroimaging studies have demonstrated activations in the lateral orbitofrontal cortex (OFC) and the inferior frontal gyrus (IFG) in subjects performing this task. Excitotoxic lesions of analogous regions in marmosets have revealed, however, that although the OFC is indeed critical for reversal learning, ventrolateral prefrontal cortex (VLPFC) (analogous to IFG) is not, contributing instead to higher order processing, such as that required in attentional set-shifting and strategy transfer. One major difference between the marmoset and human studies has been the level of training subjects received in reversal learning, being far greater in the latter. Since exposure to repeated contingency changes, as occurs in serial reversal learning, is likely to trigger the development of higher order, rule-based strategies, we hypothesized a critical role of the marmoset VLPFC in performance of a serial reversal learning paradigm. After extensive training in reversal learning, marmosets received an excitotoxic lesion of the VLPFC, OFC, or a sham control procedure. In agreement with our prediction, postsurgery, VLPFC lesioned animals were impaired in performing a series of discrimination reversals, but only when novel visual stimuli were introduced. In contrast, OFC lesioned animals were impaired regardless of whether the visual stimuli were the same or different from those used during presurgery training. Together, these data demonstrate the heterogeneous but interrelated involvement of primate OFC and VLPFC in the performance of serial reversal learning.

Entities:  

Mesh:

Year:  2010        PMID: 20980613      PMCID: PMC3044865          DOI: 10.1523/JNEUROSCI.2631-10.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  38 in total

1.  Prospective memory in the formation of learning sets by rhesus monkeys (Macaca mulatta).

Authors:  Elisabeth A Murray; David Gaffan
Journal:  J Exp Psychol Anim Behav Process       Date:  2006-01

2.  Medial frontal cortex mediates perceptual attentional set shifting in the rat.

Authors:  J M Birrell; V J Brown
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

3.  The role of ventral and orbital prefrontal cortex in conditional visuomotor learning and strategy use in rhesus monkeys (Macaca mulatta).

Authors:  T J Bussey; S P Wise; E A Murray
Journal:  Behav Neurosci       Date:  2001-10       Impact factor: 1.912

4.  Reward-related reversal learning after surgical excisions in orbito-frontal or dorsolateral prefrontal cortex in humans.

Authors:  J Hornak; J O'Doherty; J Bramham; E T Rolls; R G Morris; P R Bullock; C E Polkey
Journal:  J Cogn Neurosci       Date:  2004-04       Impact factor: 3.225

5.  Architectural subdivisions of medial and orbital frontal cortices in the marmoset monkey (Callithrix jacchus).

Authors:  Kathleen J Burman; Marcello G P Rosa
Journal:  J Comp Neurol       Date:  2009-05-01       Impact factor: 3.215

6.  Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives.

Authors:  Samuel R Chamberlain; Lara Menzies; Adam Hampshire; John Suckling; Naomi A Fineberg; Natalia del Campo; Mike Aitken; Kevin Craig; Adrian M Owen; Edward T Bullmore; Trevor W Robbins; Barbara J Sahakian
Journal:  Science       Date:  2008-07-18       Impact factor: 47.728

7.  Orbital prefrontal cortex mediates reversal learning and not attentional set shifting in the rat.

Authors:  Kerry McAlonan; Verity J Brown
Journal:  Behav Brain Res       Date:  2003-11-30       Impact factor: 3.332

8.  Strategy implementation in obsessive-compulsive disorder and trichotillomania.

Authors:  Samuel R Chamberlain; Andrew D Blackwell; Naomi A Fineberg; Trevor W Robbins; Barbara J Sahakian
Journal:  Psychol Med       Date:  2005-10-05       Impact factor: 7.723

9.  Separable learning systems in the macaque brain and the role of orbitofrontal cortex in contingent learning.

Authors:  Mark E Walton; Timothy E J Behrens; Mark J Buckley; Peter H Rudebeck; Matthew F S Rushworth
Journal:  Neuron       Date:  2010-03-25       Impact factor: 17.173

10.  Lesions of the medial striatum in monkeys produce perseverative impairments during reversal learning similar to those produced by lesions of the orbitofrontal cortex.

Authors:  Hannah F Clarke; Trevor W Robbins; Angela C Roberts
Journal:  J Neurosci       Date:  2008-10-22       Impact factor: 6.167

View more
  82 in total

Review 1.  Balkanizing the primate orbitofrontal cortex: distinct subregions for comparing and contrasting values.

Authors:  Peter H Rudebeck; Elisabeth A Murray
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

Review 2.  Serotonin and prefrontal cortex function: neurons, networks, and circuits.

Authors:  M Victoria Puig; Allan T Gulledge
Journal:  Mol Neurobiol       Date:  2011-11-11       Impact factor: 5.590

3.  Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine.

Authors:  Kathleen S Alexander; Hui-Qiu Wu; Robert Schwarcz; John P Bruno
Journal:  Psychopharmacology (Berl)       Date:  2011-10-26       Impact factor: 4.530

4.  Abnormalities in white matter tracts in the fronto-striatal-thalamic circuit are associated with verbal performance in 22q11.2DS.

Authors:  Carina Heller; Saskia Steinmann; James J Levitt; Nikos Makris; Kevin M Antshel; Wanda Fremont; Ioana L Coman; Stefan R Schweinberger; Thomas Weiß; Sylvain Bouix; Marek R Kubicki; Wendy R Kates; Zora Kikinis
Journal:  Schizophr Res       Date:  2020-10-23       Impact factor: 4.939

5.  5-HT2A receptors in the orbitofrontal cortex facilitate reversal learning and contribute to the beneficial cognitive effects of chronic citalopram treatment in rats.

Authors:  Ashley Furr; M Danet Lapiz-Bluhm; David A Morilak
Journal:  Int J Neuropsychopharmacol       Date:  2011-10-19       Impact factor: 5.176

6.  Dysregulation of D₂-mediated dopamine transmission in monkeys after chronic escalating methamphetamine exposure.

Authors:  Stephanie M Groman; Buyean Lee; Emanuele Seu; Alex S James; Karen Feiler; Mark A Mandelkern; Edythe D London; J David Jentsch
Journal:  J Neurosci       Date:  2012-04-25       Impact factor: 6.167

Review 7.  Comorbid HIV infection and alcohol use disorders: Converging glutamatergic and dopaminergic mechanisms underlying neurocognitive dysfunction.

Authors:  Laura L Giacometti; Jacqueline M Barker
Journal:  Brain Res       Date:  2019-08-14       Impact factor: 3.252

8.  I Like Them…Will They Like Me? Evidence for the Role of the Ventrolateral Prefrontal Cortex During Mismatched Social Appraisals in Anxious Youth.

Authors:  Ashley R Smith; Eric E Nelson; Brent I Rappaport; Daniel S Pine; Ellen Leibenluft; Johanna M Jarcho
Journal:  J Child Adolesc Psychopharmacol       Date:  2018-05-24       Impact factor: 2.576

9.  One-year change in cognitive flexibility and fine motor function in middle-aged male and female marmosets (Callithrix jacchus).

Authors:  Kathryn P Workman; Brianna Healey; Alyssa Carlotto; Agnès Lacreuse
Journal:  Am J Primatol       Date:  2018-10-03       Impact factor: 2.371

10.  Behavioral and emotional dysregulation trajectories marked by prefrontal-amygdala function in symptomatic youth.

Authors:  M A Bertocci; G Bebko; T Olino; J Fournier; A K Hinze; L Bonar; J R C Almeida; S B Perlman; A Versace; M Travis; M K Gill; C Demeter; V A Diwadkar; R White; C Schirda; J L Sunshine; L E Arnold; S K Holland; R A Kowatch; B Birmaher; D Axelson; E A Youngstrom; R L Findling; S M Horwitz; M A Fristad; M L Phillips
Journal:  Psychol Med       Date:  2014-01-27       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.